Old Web
English
Sign In
Acemap
>
authorDetail
>
Tamás Suto
Tamás Suto
University of Cambridge
Darbepoetin alfa
Anemia
Medicine
Gastroenterology
Internal medicine
4
Papers
181
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Randomized, Multicenter, Controlled Trial Comparing the Efficacy and Safety of Darbepoetin Alfa Administered Every 3 Weeks With or Without Intravenous Iron in Patients With Chemotherapy-Induced Anemia
2008
Journal of Clinical Oncology
Laurent Bastit
An Vandebroek
Sevilay Altintas
Bernd Gaede
Tamás Pintér
Tamás Suto
Tony W. Mossman
Kay E. Smith
Johan F. Vansteenkiste
Show All
Source
Cite
Save
Citations (171)
Changes in iron parameters in patients (pts) with chemotherapy-induced anemia (CIA) receiving darbepoetin alfa (DA) every 3 weeks with and without intravenous iron supplementation
2007
Journal of Clinical Oncology
Tamás Suto
J. F. Vansteenkiste
Tony W. Mossman
Tamás Pintér
Show All
Source
Cite
Save
Citations (2)
Darbepoetin alfa Administered Every 3 Weeks Is Effective in Correcting Hemoglobin and Reducing Transfusion Requirements in Anemic Patients with Hematological Malignancies Receiving Chemotherapy: A Retrospective Observational Study Reflecting Real-World Clinical Practice in Europe.
2007
Blood
Bertrand Coiffier
David Coeffic
Frank Strohbach
Marcus Schweigert
Hirsh Koyi
Lisa Hamilton
Tamás Suto
Show All
Source
Cite
Save
Citations (0)
Intravenous (IV) Iron Supplementation in Patients with Chemotherapy-Induced Anemia (CIA) Receiving Darbepoetin alfa Every 3 Weeks (Q3W): Iron Parameters in a Randomized Controlled Trial.
2006
Blood
Christian Lerchenmueller
Faress Husseini
Bernd Gaede
Tony W. Mossman
Tamás Suto
An Vanderbroek
Show All
Source
Cite
Save
Citations (8)
1
map